HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Serum and liver glycylproline dipeptidyl aminopeptidase activity in rats with experimental hepatic cancer.

Abstract
Changes of glycylproline dipeptidyl aminopeptidase (GPDA) and gamma-glutamyl transpeptidase (gamma-GTP) activities were compared in the serum and liver tissue of rats with hepatic cancer induced by 3'-methyl DAB. Serum glycylproline dipeptidyl aminopeptidase activity in rats with the azo dye-induced hepatic cancer was significantly higher than that in healthy rats, but the increase was not so extensive compared with that of gamma-glutamyl transpeptidase. The specific activity of glycylproline dipeptidyl aminopeptidase was decrease in the microsomal fraction and increased in the supernatant fraction of hepatic cancer tissue, whereas that of gamma-glutamyl transpeptidase was increased in both microsomal and supernatant fractions. These results suggest that the mechanisms, whereby serum activities of these two enzymes were increased in rats with hepatic cancer, were different from each other.
AuthorsJ Kojima, M Kanatani, N Nakamura, T Kashiwagi, F Tohjoh, M Akiyama
JournalClinica chimica acta; international journal of clinical chemistry (Clin Chim Acta) Vol. 107 Issue 1-2 Pg. 105-10 (Oct 23 1980) ISSN: 0009-8981 [Print] Netherlands
PMID6107182 (Publication Type: Journal Article)
Chemical References
  • Dipeptides
  • Methyldimethylaminoazobenzene
  • gamma-Glutamyltransferase
  • Aminopeptidases
  • glycylproline dipeptidyl aminopeptidase
Topics
  • Aminopeptidases (metabolism)
  • Animals
  • Dipeptides (metabolism)
  • Liver (enzymology)
  • Liver Neoplasms (enzymology)
  • Male
  • Methyldimethylaminoazobenzene
  • Neoplasms, Experimental (chemically induced, enzymology)
  • Rats
  • gamma-Glutamyltransferase (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: